Literature DB >> 30426871

A Public Health Strategy for the Opioid Crisis.

Brendan Saloner1, Emma E McGinty1, Leo Beletsky2,3, Ricky Bluthenthal4, Chris Beyrer5, Michael Botticelli1,5,6, Susan G Sherman7.   

Abstract

Drug overdose is now the leading cause of injury death in the United States. Most overdose fatalities involve opioids, which include prescription medication, heroin, and illicit fentanyl. Current data reveal that the overdose crisis affects all demographic groups and that overdose rates are now rising most rapidly among African Americans. We provide a public health perspective that can be used to mobilize a comprehensive local, state, and national response to the opioid crisis. We argue that framing the crisis from a public health perspective requires considering the interaction of multiple determinants, including structural factors (eg, poverty and racism), the inadequate management of pain, and poor access to addiction treatment and harm-reduction services (eg, syringe services). We propose a novel ecological framework for harmful opioid use that provides multiple recommendations to improve public health and clinical practice, including improved data collection to guide resource allocation, steps to increase safer prescribing, stigma-reduction campaigns, increased spending on harm reduction and treatment, criminal justice policy reform, and regulatory changes related to controlled substances. Focusing on these opportunities provides the greatest chance of making a measured and sustained impact on overdose and related harms.

Entities:  

Keywords:  addiction; health disparities; health policy; injury; pain management; stigma

Mesh:

Year:  2018        PMID: 30426871      PMCID: PMC6243441          DOI: 10.1177/0033354918793627

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  69 in total

1.  Social Stigma Toward Persons With Prescription Opioid Use Disorder: Associations With Public Support for Punitive and Public Health-Oriented Policies.

Authors:  Alene Kennedy-Hendricks; Colleen L Barry; Sarah E Gollust; Margaret E Ensminger; Margaret S Chisolm; Emma E McGinty
Journal:  Psychiatr Serv       Date:  2017-01-03       Impact factor: 3.084

2.  Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.

Authors:  Michael A Irvine; Jane A Buxton; Michael Otterstatter; Robert Balshaw; Reka Gustafson; Mark Tyndall; Perry Kendall; Thomas Kerr; Mark Gilbert; Daniel Coombs
Journal:  Lancet Public Health       Date:  2018-04-18

3.  Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure.

Authors:  Evan Wood; Mark W Tyndall; Patricia M Spittal; Kathy Li; Aslam H Anis; Robert S Hogg; Julio S G Montaner; Michael V O'Shaughnessy; Martin T Schechter
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

4.  Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis.

Authors:  Hsien-Yen Chang; Tatyana Lyapustina; Lainie Rutkow; Matthew Daubresse; Matt Richey; Mark Faul; Elizabeth A Stuart; G Caleb Alexander
Journal:  Drug Alcohol Depend       Date:  2016-06-02       Impact factor: 4.492

5.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.

Authors:  Yuhua Bao; Yijun Pan; Aryn Taylor; Sharmini Radakrishnan; Feijun Luo; Harold Alan Pincus; Bruce R Schackman
Journal:  Health Aff (Millwood)       Date:  2016-06-01       Impact factor: 6.301

Review 6.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

7.  Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study.

Authors:  Christina M Andrews; Colleen M Grogan; Melissa A Westlake; Amanda J Abraham; Harold A Pollack; Thomas A D'Aunno; Peter D Friedmann
Journal:  J Subst Abuse Treat       Date:  2018-02-03

8.  Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.

Authors:  Amos Irwin; Ehsan Jozaghi; Brian W Weir; Sean T Allen; Andrew Lindsay; Susan G Sherman
Journal:  Harm Reduct J       Date:  2017-05-12

9.  Two steps forward, one step back: current harm reduction policy and politics in the United States.

Authors:  Ethan Nadelmann; Lindsay LaSalle
Journal:  Harm Reduct J       Date:  2017-06-12
View more
  54 in total

1.  Implementation and enforcement of state opioid prescribing laws.

Authors:  Elizabeth M Stone; Lainie Rutkow; Mark C Bicket; Colleen L Barry; G Caleb Alexander; Emma E McGinty
Journal:  Drug Alcohol Depend       Date:  2020-06-11       Impact factor: 4.492

2.  Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem.

Authors:  Brandon G Bergman; Robert D Ashford; John F Kelly
Journal:  Exp Clin Psychopharmacol       Date:  2019-09-26       Impact factor: 3.157

3.  Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.

Authors:  Elizabeth C Saunders; Sarah K Moore; Olivia Walsh; Stephen A Metcalf; Alan J Budney; Emily Scherer; Lisa A Marsch
Journal:  J Subst Abuse Treat       Date:  2020-01-21

4.  Expanding a Comprehensive Strategy for Overdose Prevention in the USA.

Authors:  David Vlahov
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

5.  Can the United States Achieve Human Immunodeficiency Virus Epidemic Control? A New Initiative Offers Hope.

Authors:  Carlos Del Rio; Wendy S Armstrong; James Curran
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

6.  Public Health Rising to the Challenge: The Bloomberg American Health Initiative.

Authors:  Joshua M Sharfstein; Jessica Leighton; Alfred Sommer; Ellen J MacKenzie
Journal:  Public Health Rep       Date:  2018 Nov/Dec       Impact factor: 2.792

7.  The Bloomberg American Health Initiative.

Authors:  Ellen J MacKenzie; Michael J Klag; Alfred Sommer
Journal:  Public Health Rep       Date:  2018 Nov/Dec       Impact factor: 2.792

8.  Opioid-related overdose deaths among African Americans: Implications for research, practice and policy.

Authors:  Danelle Stevens-Watkins
Journal:  Drug Alcohol Rev       Date:  2020-04-12

9.  Understanding the increase in opioid overdoses in New Hampshire: A rapid epidemiologic assessment.

Authors:  Andrea Meier; Sarah K Moore; Elizabeth C Saunders; Bethany McLeman; Stephen A Metcalf; Samantha Auty; Olivia Walsh; Lisa A Marsch
Journal:  Drug Alcohol Depend       Date:  2020-02-07       Impact factor: 4.492

10.  Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.

Authors:  Noa Krawczyk; Ramin Mojtabai; Elizabeth A Stuart; Michael Fingerhood; Deborah Agus; B Casey Lyons; Jonathan P Weiner; Brendan Saloner
Journal:  Addiction       Date:  2020-02-24       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.